Nitroglycerin Structural Formula (Image 01)
Nitroglycerin Patch
Product Images NDC 0378-9102
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Nitroglycerin (NDC 0378-9102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Patch Cross Section (Image 02)
This text appears to be describing the properties of a product, likely an adhesive or coating. The product is impermeable and has a peelable protective backing. It also contains nitroglycerin, which may suggest medical or industrial applications. However, the text is incomplete and difficult to interpret without further context or information.*
Patient Information Figure 01 (Image 03)
Patient Information Figure 02 (Image 04)
Patient Information Figure 03 (Image 05)
Patient Information Figure 04 (Image 06)
Patient Information Figure 05 (Image 07)
Nitroglycerin Transdermal System 0.1 mg/hr Carton (Image 08)
This is a description of a transdermal system for the drug Nitroglycerin. The system contains 11.2mg of nitroglycerin and is for transdermal use only. The inactive components consist of acryl, polyester, silicone, and other materials. The system should be stored in a controlled room temperature. The text also includes some warnings and instructions.*
Nitroglycerin Transdermal System 0.2 mg/hr Carton (Image 09)
This is a description of the Nitroglycerin Transdermal System manufactured by Mylan. Each system contains 22.4 mg of nitroglycerin and various adhesive components. The product is for transdermal use only and should be applied immediately upon removal from the packaging. The text includes instructions for application and a patient should read and follow the instructions carefully. The blurred and distorted characters make it difficult to understand the last part of the text.*
Nitroglycerin Transdermal System 0.4 mg/hr Carton (Image 10)
This is a description of a nitroglycerin transdermal system, which is a prescription-only medication used to treat symptoms related to chest pain caused by angina. Each patch contains 44.8 mg of nitroglycerin, and the instructions for use include opening the pouch, carefully removing the patch, placing it on the chosen skin site and pressing it firmly in place, with the recommendation to not touch the exposed sticky side of the patch. The system contains inert components such as acryl pressure-sensitive adhesive, with a cross-linking agent polyolefin, polyester elastomer coated on PET film with silicones and white ink containing tartrazine. This product is for transdermal use only and the instructions have more detailed information on the back panel.*
Nitroglycerin Transdermal System 0.6 mg/hr Carton (Image 11)
This is a description for a Nitroglycerin Transdermal System used for transdermal applications. Each 24-hour system contains 67.2 mg of nitroglycerin, and its inactive components include acrylic pressure-sensitive adhesive with a cross-linking agent, polyolefin film, polyester release liner coated on one side with silicone and white ink containing titanium dioxide. The release rate is at 0.6 ma/h. Instructions for application are also available on the packaging.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
